利尿剂|主任提问:糖尿病患者降血压,还用利尿剂吗?( 三 )


[11]孙宁玲,王鸿懿.高血压合并2型糖尿病患者的血压控制专家指导意见(2013版)[J].中华高血压杂志,2013,21(06):522-525
[12]de Boer IH, Bangalore S, Benetos A, etal. Diabetes and hypertension: a position statement by the American DiabetesAssociation. Diabetes Care, 2017, 40(9): 1273-1284
[13]成人糖尿病患者血压管理专家共识[J].上海医学,2021,44(01):8-18
[14]Hackam DG, Khan NA, H emmelgarn BR, etal .The 2010 Canadian hypertension programm e recomm endati on f or the management of hypertensi on-Part2[ J] .Can J Cardi ol, 2010, 26 ( 5) :249-258
[15]Ernst ME,Mann SJ.Diuretics inthe treatment of hypertension[J].Semin Nephrol,2011,31( 6) : 495-502.
[16]Law MR,Morris JK,Wald NJ.Use of bloodpressure lowering drugs in the prevention of cardiovascular disease:meta-analysis of 147 randomised trials in the context of expectation fromprospective epidemiological studies[J].BMJ,2009,338: b1665.
[17]Patel A,Macmahon S,Chalmers J,et al.Effects of afixed combination of perindopril and indapamide on macrovascular andmicrovascular outcomes in patients with type 2 diabetes mellitus( the ADVANCEtrial) : a randomised controlled trial[J].Lancet,2007,370( 9590): 829-840.
[18]SHEP Cooperative Research Group. Preventionof stroke by antihypertensive drug treatment in older persons with isolatedsystolic hypertension.Final result of the Systolic Hypertension in the Elderly Program (SHEP).JAMA 1991265:3255-3264
[19]Neaton JD Grimm RH Jr Prineas RJ et al.Treatment ofmild hypertension study.Final results.JAMA 1993 270:713-724.
[20]Hollenberg NK Mickiewicz CW.Postmarketingsurveillance in70898 patients treated with a triamtereneydrochlorothiazide combination.Am J Cardiol1989 63:37B-41B.
[21]Maroko PR McDevitt JT Fox MJ et al.Antihypertensiveeffectiveness of very low doses of hydrochlorothiazide result of the PHICOGtrial.Clin Ther 1989 11:94-119
[22]Am erican Diabetes Ass oci at ion .Standards of medi cal Care in diabet es-2010[ J] .Diab et es Care, 2010, 32( Supp 1) :11-61
[23]李春红, 董哲. 心血管内科疾病治疗中利尿剂使用的不良反应分析 [J]. 中西医结合心血管病杂志 (电子版), 2016, 4(1): 44-46.

推荐阅读